Swing Care, a virtual specialty clinic for comprehensive fibromyalgia treatment, announced that Big Health’s flagship insomnia treatment, SleepioRx, is now available by prescription to eligible patients.
SleepioRx is a clinically proven, FDA-cleared treatment designed to help those with insomnia tackle the root causes of their sleep problems. Through a self-paced, app-delivered program, SleepioRx delivers first-line cognitive behavioral therapy (CBT) to help patients better understand their sleep patterns and make lasting improvements.
Fibromyalgia affects over 4% of Americans, causing widespread musculoskeletal pain, fatigue, and sleep problems. For many, poor sleep exacerbates pain symptoms, making sleep management a crucial component of care. In a survey of the symptoms most affecting quality of life in patients with fibromyalgia, fatigue was the top response, affecting 3 in 4 patients.
Starting January 1, 2025, CMS introduced new Medicare reimbursement for digital mental health treatments including SleepioRx, allowing patients to get access to this evidence-based treatment through their insurance.
“By integrating SleepioRx into Swing Care’s offerings for Medicare members, we are taking a huge step toward improving the quality of life for people with fibromyalgia,” said Andrea Chadwick, MD, Medical Director at Swing Care. “Improving sleep has a major impact on the physical and emotional toll of living with chronic pain.”
“SleepioRx offers a clinically proven, patient-friendly approach to improving sleep,” said Yael Berman, CEO of Big Health. “By partnering with Swing Care, we’re ensuring fibromyalgia patients have immediate access to first-line sleep treatment so they can experience an overall improvement in health.”
If you or a loved one is enrolled in Medicare and living with fibromyalgia, learn more about Swing Care and comprehensive fibromyalgia treatment at www.swing.care.
